Full text is available at the source.
Abstract
Perioperative use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be linked to postoperative outcomes after breast cancer surgery.
- The study focuses on evaluating safety concerns associated with GLP-1 RAs in the context of breast cancer surgery.
- 30-day postoperative outcomes were assessed following the use of GLP-1 RAs during the perioperative period.
- Uncertainty exists regarding the impact of GLP-1 RA use on surgical recovery and complications in breast cancer patients.
Simplified